Biotest AG

    Biotest AG

    XXETR:BIO
    40.00
    EUR
    +0.80
    (+2.04%)
    71.37P/E
    Biotest AG
    XETR:BIO
    (Deutsche Borse Xetra)

    Recent

    price

    40.00

    P/E

    ratio

    71.37

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    EUR
    11.09
    11.72
    11.99
    12.51
    13.39
    14.71
    13.51
    10.31
    9.55
    10.12
    10.59
    12.24
    13.03
    13.04
    17.3
    - -
    16.35
    Revenue per Share
    0.8
    1.12
    1.32
    0.94
    0.84
    0.48
    -2.09
    -1.16
    -0.1
    4.58
    -0.13
    -0.8
    -1.61
    -0.81
    3.21
    - -
    -0.63
    Basic EPS, GAAP
    -0.16
    1.38
    1.29
    -0.02
    -1.34
    -1.42
    -1.41
    -5.34
    -1.82
    -2.64
    -1.71
    -1.1
    0.4
    -1.76
    -0.91
    - -
    0.37
    Free Cash Flow per Basic Share
    0.11
    0.12
    0.14
    0.16
    0.17
    0.2
    0.21
    0.03
    0.06
    0.02
    0.02
    0.02
    0.02
    0.02
    - -
    - -
    - -
    Dividend per Share
    1.58
    1.9
    2.17
    6.14
    6.28
    6.43
    4.86
    3.56
    3.23
    6.95
    6.5
    5.61
    4.06
    3.82
    7.31
    - -
    7.54
    Book Value per Share
    5.77
    6.9
    8.15
    8.62
    10.58
    10.44
    8.79
    7.98
    7.87
    11.6
    11.7
    10.81
    9.33
    8.96
    12.23
    - -
    12.7
    Tangible Book Value per Share
    35
    35
    35
    35
    37
    40
    40
    40
    40
    40
    40
    40
    40
    40
    40
    - -
    39
    Basic Weighted Avg Shares
    390
    412
    422
    440
    501
    582
    535
    408
    378
    400
    419
    484
    516
    516
    685
    726
    635
    Sales/Revenue/Turnover
    14.63
    10.4
    10.27
    11.36
    10.04
    9.12
    6.9
    8.31
    -8.81
    0.62
    -1.6
    -0.52
    -10.1
    -1.65
    18.89
    11.8
    1.72
    Operating Margin (%)
    25
    27
    31
    31
    32
    33
    22
    20
    22
    25
    32
    30
    31
    36
    36
    41
    - -
    Depreciation Expense
    28
    39
    46
    33
    32
    19
    -82
    -46
    -3
    182
    -5
    -31
    -63
    -32
    127
    26
    -24
    Net Income, GAAP
    34.86
    31.02
    34.46
    36.71
    33.05
    59.06
    22.41
    74.58
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    43.44
    323.93
    Effective Tax Rate (%)
    7.18
    9.57
    10.98
    7.59
    6.39
    3.3
    -15.43
    -11.23
    -0.93
    45.39
    -1.12
    -6.48
    -12.3
    -6.14
    18.55
    3.64
    -3.86
    Profit Margin (%)
    176
    178
    222
    203
    438
    550
    461
    321
    199
    370
    408
    451
    416
    489
    371
    649
    629
    Working Capital
    - -
    - -
    101
    71
    226
    326
    336
    330
    287
    329
    402
    461
    490
    565
    382
    592
    - -
    LT Debt
    270
    308
    347
    369
    461
    480
    412
    361
    348
    495
    477
    442
    380
    371
    499
    531
    510
    Total Equity
    13.88
    9.99
    7
    6.46
    5.7
    2.86
    3.63
    1.18
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    4.37
    - -
    Return on Invested Capital (%)
    70.02
    90.07
    38.1
    13.33
    8.65
    4.38
    -13.07
    -8.02
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    4.99
    34.21
    Return on Capital (%)
    50.28
    64.38
    64.67
    22.64
    14.01
    7.68
    -37.1
    -27.5
    -2.91
    89.98
    -1.92
    -13.28
    -33.37
    -20.58
    57.64
    8.75
    -8.15
    Return on Common Equity (%)

    Capital Structure

    EUR

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    ST Debt
    - -
    6
    - -
    LT Borrowings
    - -
    539
    - -
    LT Finance Leases
    - -
    53
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    40
    40
    40
    Market Capitalization
    1,629
    1,613
    1,585

    Working Capital

    EUR

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    Total Current Assets
    705
    810
    789
    Cash, Cash Equivalents & STI
    38
    120
    60
    Accounts Receivable, Net
    132
    158
    155
    Inventories
    488
    480
    524
    Total Current Liabilities
    277
    160
    160
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    6
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    2.56%
    3.42%
    6.37%
    Free Cash Flow
    -73.22%
    -190.69%
    -189.2%
    Net Income, GAAP
    -602.04%
    8.03%
    -79.21%
    Sales/Revenue/Turnover
    3.23%
    12.17%
    6.08%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    117
    158
    225
    184
    685
    2024
    215
    157
    151
    204
    726
    2025
    124
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.53
    0.55
    2.18
    - -
    3.21
    2024
    0.74
    0.24
    -0.25
    - -
    - -
    2025
    -0.55
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business